INVESTOR DEADLINE NEXT WEEK: ModivCare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MODV

Core Viewpoint - ModivCare, Inc. is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934, with claims related to misleading statements and insufficient liquidity impacting the company's financial performance [1][2]. Group 1: Allegations and Financial Impact - The lawsuit claims that ModivCare made false or misleading statements regarding contract renegotiations and pricing accommodations, which negatively affected the company's adjusted EBITDA [2]. - It is alleged that ModivCare had insufficient liquidity during the class period, further exacerbating its financial challenges [2]. Group 2: Legal Process and Participation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased ModivCare securities during the class period to seek appointment as lead plaintiff in the lawsuit [3]. - The lead plaintiff is expected to have the greatest financial interest in the case and will represent the interests of all class members [3]. Group 3: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud cases, having secured over $6.6 billion for investors in related class action cases [4]. - The firm has been recognized for its significant recoveries, including the largest securities class action recovery in history amounting to$7.2 billion in the Enron case [4].